Erisyon
AcquiredCharting the new era of proteomics.
Austin, United States · Founded 2018
- Headquarters
- Austin, Texas
- Founded
- 2018
- Business Model
- B2B
- Website
- erisyon.com
About
Erisyon Inc. is commercializing the world's first single-molecule protein sequencer to transform how disease is detected, treated, and tracked. The company inherited more than a decade of work at the University of Texas at Austin's Center for Systems and Synthetic Biology and was founded in March 2018 by technologists and entrepreneurs. Erisyon applies fluorosequencing, its single-molecule protein sequencing platform, to proteomics research including biomarker detection and quantification.
Summary
Erisyon is a Biotech company based in Austin, United States, founded in 2018.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/erisyon"><img src="https://indexed.vc/api/badge/company/erisyon" alt="Erisyon on Indexed.vc" width="260" height="76" /></a>